{"id":"parecoxib","rwe":[],"tags":[{"label":"parecoxib","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Prostaglandin G/H synthase 2","category":"target"},{"label":"PTGS2","category":"gene"},{"label":"NR4A2","category":"gene"},{"label":"PTGS1","category":"gene"},{"label":"M01AH04","category":"atc"},{"label":"Active","category":"status"},{"label":"Acute postoperative pain","category":"indication"},{"label":"Analgesics","category":"pharmacology"},{"label":"Analgesics, Non-Narcotic","category":"pharmacology"},{"label":"Anti-Inflammatory Agents","category":"pharmacology"},{"label":"Anti-Inflammatory Agents, Non-Steroidal","category":"pharmacology"},{"label":"Antirheumatic Agents","category":"pharmacology"},{"label":"Cyclooxygenase 2 Inhibitors","category":"pharmacology"},{"label":"Cyclooxygenase Inhibitors","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sensory System Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":146.826,"date":"","count":17,"signal":"Negative pressure pulmonary oedema","source":"DrugCentral FAERS","actionTaken":"Reported 17 times (LLR=147)"},{"llr":74.465,"date":"","count":11,"signal":"Neuromuscular block prolonged","source":"DrugCentral FAERS","actionTaken":"Reported 11 times (LLR=74)"},{"llr":63.693,"date":"","count":17,"signal":"Tachypnoea","source":"DrugCentral FAERS","actionTaken":"Reported 17 times (LLR=64)"},{"llr":61.411,"date":"","count":21,"signal":"Anaphylactic reaction","source":"DrugCentral FAERS","actionTaken":"Reported 21 times (LLR=61)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=PARECOXIB","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:56:46.625390+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:57:00.293134+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:56:52.190146+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-20T01:56:46.698137+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PARECOXIB","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:56:52.556890+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cyclooxygenase-2 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:56:53.598350+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1206690/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:56:53.255374+00:00"}},"allNames":"xapit","offLabel":[],"synonyms":["dynastat","parecoxib","parecoxib sodium","xapit"],"timeline":[{"date":"2002-03-22","type":"positive","source":"DrugCentral","milestone":"EMA approval"}],"aiSummary":"Parecoxib (Xapit) is a marketed selective COX-2 inhibitor primarily indicated for acute postoperative pain management. Its key strength lies in its mechanism of action, which selectively targets the enzyme responsible for pain and inflammation, potentially offering a safer profile compared to non-selective NSAIDs. The primary risk is the upcoming key composition patent expiry in 2028, which could lead to increased competition from generics.","approvals":[{"date":"2002-03-22","orphan":false,"company":"","regulator":"EMA"}],"brandName":"Xapit","ecosystem":[{"indication":"Acute postoperative pain","otherDrugs":[{"name":"buprenorphine","slug":"buprenorphine","company":"Reckitt Benckiser"},{"name":"celecoxib","slug":"celecoxib","company":"Gd Searle"},{"name":"fentanyl","slug":"fentanyl","company":"Akorn"},{"name":"hydromorphone","slug":"hydromorphone","company":"Purdue Pharm Prods"}],"globalPrevalence":null}],"mechanism":{"target":"Prostaglandin G/H synthase 2","targets":[{"gene":"PTGS2","source":"DrugCentral","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2"},{"gene":"NR4A2","source":"DrugCentral","target":"Nuclear receptor subfamily 4 group A member 2","protein":"Nuclear receptor subfamily 4 group A member 2"},{"gene":"PTGS1","source":"DrugCentral","target":"Prostaglandin G/H synthase 1","protein":"Prostaglandin G/H synthase 1"}],"modality":"Small Molecule","drugClass":"parecoxib","explanation":"","oneSentence":"","technicalDetail":"Xapit exerts its analgesic and anti-inflammatory effects through the selective inhibition of cyclooxygenase-2 (COX-2), a key enzyme involved in the conversion of arachidonic acid to prostaglandin H2, which is then converted to other prostaglandins that mediate pain and inflammation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2063","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=PARECOXIB","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PARECOXIB","fields":["publications"],"source":"PubMed/NCBI"}],"_emaChecked":true,"_enrichedAt":"2026-03-30T15:15:30.493202","_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:57:00.293225+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"celecoxib","drugSlug":"celecoxib","fdaApproval":"1998-12-31","patentExpiry":"May 27, 2036","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"rofecoxib","drugSlug":"rofecoxib","fdaApproval":"1999-05-20","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"valdecoxib","drugSlug":"valdecoxib","fdaApproval":"2001-11-16","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"parecoxib","indications":{"approved":[{"name":"Acute postoperative pain","source":"DrugCentral","snomedId":107401000119105,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"celecoxib","brandName":"celecoxib","genericName":"celecoxib","approvalYear":"1998","relationship":"same-class"},{"drugId":"rofecoxib","brandName":"rofecoxib","genericName":"rofecoxib","approvalYear":"1999","relationship":"same-class"},{"drugId":"valdecoxib","brandName":"valdecoxib","genericName":"valdecoxib","approvalYear":"2001","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07154433","phase":"NA","title":"A Study on Reducing Opioid Use After Minimally Invasive Ankle Surgery","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":["Ankle (Ligaments); Instability (Old Injury)","Ankle Sprain","Talus Osteochondral Defect","Opioid Analgesia","Non-Opioid Pain Management"],"enrollment":110,"completionDate":"2026-07-01"},{"nctId":"NCT07337135","phase":"NA","title":"Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery","status":"COMPLETED","sponsor":"Hospital dos Lusíadas","startDate":"2023-10-02","conditions":["Morbid Obesity","Postoperative Pain","Opioid Free Anesthesia","Bariatric Surgery"],"enrollment":60,"completionDate":"2024-04-21"},{"nctId":"NCT07414706","phase":"PHASE3","title":"Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-03","conditions":["Intravenous Lidocaine","Laparoscopic Surgery","Post Operative Recovery","Local Anaesthetic Systemic Toxicity"],"enrollment":182,"completionDate":"2028-09"},{"nctId":"NCT07154446","phase":"PHASE4","title":"Study Comparing Dynastat and Parestat Pain Relief Medications for Patients After Breast Surgery","status":"NOT_YET_RECRUITING","sponsor":"University of Malaya","startDate":"2025-10-01","conditions":["Breast Exicision Biopsy"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT07139691","phase":"NA","title":"TAP Block With Lidocaine and Ropivacaine 0.2% (0.4 ml/kg/Side) for Pain and Opioid Reduction After Hysterectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Matild Keresztes","startDate":"2024-01-12","conditions":["Postoperative Pain Following Hysterectomy"],"enrollment":82,"completionDate":"2026-12-31"},{"nctId":"NCT07116304","phase":"NA","title":"Comparative Efficacy of IV Parecoxib vs Lidocaine in Reducing Propofol Injection Pain","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2025-08-01","conditions":["Preventing Propofol Pain on Injection"],"enrollment":30,"completionDate":"2026-12-30"},{"nctId":"NCT05924412","phase":"PHASE4","title":"Parecoxib in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"University of Chile","startDate":"2023-07-06","conditions":["Pain, Postoperative","Pain, Acute","Analgesia","Analgesic Nephropathy","Analgesic Adverse Reaction","Knee Osteoarthritis"],"enrollment":40,"completionDate":"2024-09-01"},{"nctId":"NCT06315920","phase":"PHASE3","title":"Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-05-01","conditions":["Sickle-Cell Disease with Crisis"],"enrollment":226,"completionDate":"2028-07-01"},{"nctId":"NCT06834425","phase":"NA","title":"Efficacy of NSAID Peritendinous Injection for Acute Tendinitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Taipei Medical University WanFang Hospital","startDate":"2025-02-10","conditions":["Tendinitis","Acute Tendonitis","NSAID (Non-Steroidal Anti-Inflammatory Drug)"],"enrollment":40,"completionDate":"2026-03-01"},{"nctId":"NCT06721988","phase":"NA","title":"Effect of Preventive Analgesia with Oxycodone and Parecoxib Sodium on the Chronification of Acute Post-operative Pain","status":"NOT_YET_RECRUITING","sponsor":"Ailin Luo","startDate":"2025-01-01","conditions":["Oxycodone","Chronic Pain, Postoperative"],"enrollment":1316,"completionDate":"2027-04-30"},{"nctId":"NCT06140238","phase":"PHASE4","title":"Preemptive Analgesic Efficacy of Parecoxib for Reducing Postoperative Pain in Gynecological Surgery","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2023-09-10","conditions":["Preemptive Analgesia","Gynecological Surgery","Postoperative Pain","Parecoxib"],"enrollment":178,"completionDate":"2024-06-27"},{"nctId":"NCT06623513","phase":"PHASE2","title":"Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-10-01","conditions":["Pancreatitis, Acute","Cholangiopancreatography, Endoscopic Retrograde"],"enrollment":100,"completionDate":"2026-09-30"},{"nctId":"NCT06600282","phase":"PHASE4","title":"Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions","status":"NOT_YET_RECRUITING","sponsor":"Yung Shin Pharm. Ind. Co., Ltd.","startDate":"2024-10-01","conditions":["Post-operative Pain","Bioequivalence Study in Healthy Subjects"],"enrollment":14,"completionDate":"2024-12-30"},{"nctId":"NCT06579274","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of Parecoxib in Patients With Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"St. Anne's University Hospital Brno, Czech Republic","startDate":"2025-01-01","conditions":["Neurological Complication"],"enrollment":112,"completionDate":"2027-07-01"},{"nctId":"NCT06420388","phase":"NA","title":"2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy","status":"RECRUITING","sponsor":"E-DA Hospital","startDate":"2023-05-01","conditions":["Surgery","Pain, Postoperative"],"enrollment":400,"completionDate":"2024-10-01"},{"nctId":"NCT05681429","phase":"NA","title":"Accelerated Recovery Following Opioid-free Anaesthesia in Supratentorial Craniotomy","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2023-01-01","conditions":["Opioid-Free Anaesthesia"],"enrollment":25,"completionDate":"2024-01-31"},{"nctId":"NCT06304181","phase":"NA","title":"Effect of Paracetamol and Mannitol Injection on Postoperative Analgesia in Patients With Thoracoscopic Lobectomy","status":"NOT_YET_RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2024-03-15","conditions":["Postoperative Analgesia"],"enrollment":90,"completionDate":"2024-12-30"},{"nctId":"NCT04920019","phase":"NA","title":"Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2020-10-22","conditions":["Hepatoma","Pancreas Cancer"],"enrollment":140,"completionDate":"2023-08-20"},{"nctId":"NCT05150431","phase":"PHASE4","title":"Optimized Acute Pain Control With Parecoxib in Uniportal Video-assisted Thoracoscopic Surgery.","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2021-12-15","conditions":["Perioperative Care","Chronic Post-operative Pain"],"enrollment":58,"completionDate":"2022-05-01"},{"nctId":"NCT05757388","phase":"NA","title":"Efficacy of Parecoxib Combined With Paracetamol in Mastectomy","status":"UNKNOWN","sponsor":"Khon Kaen University","startDate":"2023-03-28","conditions":["Post Operative Pain"],"enrollment":60,"completionDate":"2023-05-10"},{"nctId":"NCT05442411","phase":"PHASE1","title":"Regional Scalp Block Versus IV Parecoxib for Post-operative Cranioplasty Surgery Pain: A Comparison of Pain Score.","status":"COMPLETED","sponsor":"Universiti Sains Malaysia","startDate":"2021-03-09","conditions":["Postoperative Pain"],"enrollment":58,"completionDate":"2022-03-30"},{"nctId":"NCT04767256","phase":"NA","title":"Intravenous Dexamethasone and Dexmedetomidine on the Analgesic Efficacy of Erector Spinae Plane Block","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2021-03-01","conditions":["Dexamethasone","Dexmedetomidine","Nerve Block"],"enrollment":120,"completionDate":"2021-12-30"},{"nctId":"NCT04847024","phase":"NA","title":"Parecoxib vs. Dexketoprofen for the Management of Pain After Cesarean Section.","status":"COMPLETED","sponsor":"Saint Thomas Hospital, Panama","startDate":"2019-07-01","conditions":["Caesarean Section; Pain"],"enrollment":380,"completionDate":"2019-09-30"},{"nctId":"NCT04611685","phase":"NA","title":"Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-10-31","conditions":["Pituitary Adenoma","Surgery","Pain"],"enrollment":202,"completionDate":"2021-10"},{"nctId":"NCT03704623","phase":"PHASE4","title":"Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2019-05-01","conditions":["Acute Renal Colic","Ureteric Stone"],"enrollment":200,"completionDate":"2020-08-15"},{"nctId":"NCT04314505","phase":"PHASE4","title":"Opioid-Sparing Protocol Comparing With Opioid-based Protocol After Bilateral Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2020-03-20","conditions":["Knee Replacement","Postoperative Pain","Opioid Use"],"enrollment":56,"completionDate":"2020-08-20"},{"nctId":"NCT04034836","phase":"PHASE4","title":"Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2019-10-12","conditions":["Pain, Postoperative","Neurosurgery"],"enrollment":132,"completionDate":"2021-12-31"},{"nctId":"NCT03823846","phase":"NA","title":"the Effect of Doctor-nurse-patient Cooperative Analgesic Linkage Program on Movement Evoked Pain","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2017-11-01","conditions":["Pain, Postoperative","Anaplasia"],"enrollment":80,"completionDate":"2020-10-01"},{"nctId":"NCT02749409","phase":"PHASE3","title":"Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture","status":"TERMINATED","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-08-08","conditions":["Parecoxib","Rib Fractures"],"enrollment":17,"completionDate":"2018-07-20"},{"nctId":"NCT03059238","phase":"PHASE3","title":"Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2016-09","conditions":["Liver Cancer","Pain Postoperative"],"enrollment":213,"completionDate":"2019-03"},{"nctId":"NCT02198924","phase":"PHASE4","title":"Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":["Pain","Inflammation"],"enrollment":246,"completionDate":"2016-12"},{"nctId":"NCT03915561","phase":"PHASE2","title":"Effect of Intravenous Dynastat on Postoperative Sore Throat","status":"UNKNOWN","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2019-03-01","conditions":["Sore Throat","Postoperative Complications"],"enrollment":140,"completionDate":"2020-11-30"},{"nctId":"NCT03480165","phase":"PHASE3","title":"The Efficacy of 20 mg Parecoxib as an Adjunct to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block for Upper Limb Surgery","status":"COMPLETED","sponsor":"Universiti Sains Malaysia","startDate":"2016-06-20","conditions":["Anesthesia; Functional","Anesthesia"],"enrollment":86,"completionDate":"2017-09-19"},{"nctId":"NCT03236051","phase":"NA","title":"Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center Study","status":"UNKNOWN","sponsor":"JIANG Zhi-Wei","startDate":"2017-02-10","conditions":["Gastric Cancer"],"enrollment":156,"completionDate":"2018-08-30"},{"nctId":"NCT03135795","phase":"PHASE4","title":"The Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by Sufentanil","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2017-02-06","conditions":["Epigenetics"],"enrollment":100,"completionDate":"2017-05-31"},{"nctId":"NCT01288924","phase":"PHASE2","title":"Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?","status":"COMPLETED","sponsor":"Chiang Mai University","startDate":"2011-02","conditions":["Shoulder Pain","Post-operative Pain"],"enrollment":160,"completionDate":"2016-01"},{"nctId":"NCT02729935","phase":"PHASE4","title":"Parecoxib for Treatment of Catheter Related Bladder Discomfort","status":"COMPLETED","sponsor":"University Tunis El Manar","startDate":"2016-03","conditions":["Postoperative Pain"],"enrollment":60,"completionDate":"2016-06"},{"nctId":"NCT02599623","phase":"NA","title":"Safety and Efficacy of Local Anesthesia in Emergency Inguinal Hernia Surgery","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2016-01","conditions":["Anesthesia","Incarcerated Inguinal Hernia"],"enrollment":80,"completionDate":"2019-12"},{"nctId":"NCT02552745","phase":"","title":"Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2014-10","conditions":["Hepatocellular Carcinoma"],"enrollment":200,"completionDate":"2015-04"},{"nctId":"NCT02569905","phase":"PHASE4","title":"Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering","status":"COMPLETED","sponsor":"Guangxi Medical University","startDate":"2014-04","conditions":["Postoperative Shivering"],"enrollment":166,"completionDate":"2015-04"},{"nctId":"NCT02272660","phase":"PHASE4","title":"Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-10","conditions":["Pain, Postoperative"],"enrollment":74,"completionDate":"2015-08"},{"nctId":"NCT01186159","phase":"PHASE4","title":"The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain","status":"COMPLETED","sponsor":"Xianwei Zhang","startDate":"2010-11","conditions":["Post-Operative Pain"],"enrollment":90,"completionDate":"2011-09"},{"nctId":"NCT02408146","phase":"NA","title":"The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver Resection","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2014-01","conditions":["Pain, Postoperative"],"enrollment":80,"completionDate":""},{"nctId":"NCT01930318","phase":"PHASE4","title":"Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic Surgery","status":"UNKNOWN","sponsor":"Jinling Hospital, China","startDate":"2013-08","conditions":["Gastrointestinal Cancer"],"enrollment":164,"completionDate":"2015-09"},{"nctId":"NCT02204878","phase":"PHASE4","title":"Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2014-07","conditions":["Hepatic Hemangioma Located in the Right Liver","Laparotomy Surgery"],"enrollment":100,"completionDate":""},{"nctId":"NCT02185924","phase":"PHASE2,PHASE3","title":"Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Asklepieion Voulas General Hospital","startDate":"2009-01","conditions":["POSTOPERATIVE ANALGESIA FOR TKA PARECOXIB/CFB"],"enrollment":90,"completionDate":"2014-02"},{"nctId":"NCT01526525","phase":"PHASE4","title":"Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy","status":"COMPLETED","sponsor":"G.Gennimatas General Hospital","startDate":"2009-07","conditions":["Pain, Postoperative"],"enrollment":70,"completionDate":"2012-02"},{"nctId":"NCT01843010","phase":"PHASE4","title":"Effect of Parecoxib on the Change of Shoulder Pain Threshold After Gynecological Laparoscopies","status":"COMPLETED","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2013-05","conditions":["Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies"],"enrollment":140,"completionDate":"2013-11"},{"nctId":"NCT00455117","phase":"PHASE4","title":"Effect of Parecoxib on Post-craniotomy Pain","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2006-09","conditions":["Anaesthesia"],"enrollment":130,"completionDate":"2008-12"},{"nctId":"NCT01859585","phase":"PHASE4","title":"Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2011-03","conditions":["Postoperative Pain"],"enrollment":96,"completionDate":"2013-03"},{"nctId":"NCT01782612","phase":"NA","title":"The Assessments of the Postoperative Recovery on Elderly Patients Received General Anesthesia or Peripheral Nerve Blocks","status":"UNKNOWN","sponsor":"Junle Liu","startDate":"2013-03","conditions":["Anesthesia","Hip Osteoarthritis"],"enrollment":100,"completionDate":"2014-03"},{"nctId":"NCT00553605","phase":"PHASE4","title":"Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-06","conditions":["Pain"],"enrollment":340,"completionDate":"2009-06"},{"nctId":"NCT01566669","phase":"NA","title":"Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery","status":"COMPLETED","sponsor":"Liu Weifeng","startDate":"2009-06","conditions":["Benign Female Reproductive System Neoplasm"],"enrollment":294,"completionDate":"2010-05"},{"nctId":"NCT01303809","phase":"NA","title":"Enhanced Recovery After Laparoscopic Sleeve Gastrectomy - a Randomised Controlled Trial","status":"COMPLETED","sponsor":"University of Auckland, New Zealand","startDate":"2011-05","conditions":["Morbid Obesity"],"enrollment":106,"completionDate":"2012-05"},{"nctId":"NCT01523379","phase":"","title":"Efficacy of Parecoxib on Patients With CRPS","status":"NO_LONGER_AVAILABLE","sponsor":"Ruhr University of Bochum","startDate":"","conditions":["Causalgia"],"enrollment":0,"completionDate":""},{"nctId":"NCT00435747","phase":"PHASE4","title":"Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"","conditions":["Pain, Postoperative"],"enrollment":0,"completionDate":""},{"nctId":"NCT01541137","phase":"NA","title":"NSAIDs With Morphine-PCA Compared to Epidural Analgesia in Thoracotomy Pain","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2004-03","conditions":["Postoperative Pain"],"enrollment":30,"completionDate":"2008-09"},{"nctId":"NCT01393925","phase":"NA","title":"Effect of Parecoxib on Postoperative Shoulder Pain After Gynecological Laparoscopy.","status":"COMPLETED","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2011-07","conditions":["Anti-Inflammatory Agents, Non-Steroidal","Pain, Postoperative","Laparoscopy"],"enrollment":126,"completionDate":"2011-11"},{"nctId":"NCT00443404","phase":"PHASE2,PHASE3","title":"Optimized Perioperative Analgesia Reduces the Prevalence and the Intensity of Phantom Pain in Lower Limb Amputation","status":"COMPLETED","sponsor":"University of Patras","startDate":"2003-12","conditions":["Phantom Limb Pain"],"enrollment":60,"completionDate":"2009-05"},{"nctId":"NCT00346268","phase":"PHASE4","title":"Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy","status":"TERMINATED","sponsor":"Pfizer","startDate":"2006-12","conditions":["Pain, Postoperative"],"enrollment":105,"completionDate":"2010-09"},{"nctId":"NCT00785863","phase":"PHASE4","title":"Modulation of Remifentanil-induced Postinfusion Hyperalgesia","status":"COMPLETED","sponsor":"Ullevaal University Hospital","startDate":"2008-12","conditions":["Hyperalgesia, Secondary"],"enrollment":16,"completionDate":"2009-04"},{"nctId":"NCT01361789","phase":"PHASE4","title":"COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined","status":"COMPLETED","sponsor":"Asker & Baerum Hospital","startDate":"2004-01","conditions":["Rupture of Anterior Cruciate Ligament"],"enrollment":93,"completionDate":"2009-12"},{"nctId":"NCT01221025","phase":"PHASE4","title":"Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2010-09","conditions":["Emergence Delirium","Postoperative Pain"],"enrollment":900,"completionDate":"2012-06"},{"nctId":"NCT01311804","phase":"PHASE3","title":"An Efficacy and Safety Study of Periarticular Parecoxib Sodium for Pain Management in Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Ministry of Health, Malaysia","startDate":"2011-04","conditions":["Unilateral Primary Osteoarthritis of Knee"],"enrollment":125,"completionDate":"2011-10"},{"nctId":"NCT00139607","phase":"PHASE3","title":"Parecoxib In Post Surgery (Hemicolectomy) Pain","status":"TERMINATED","sponsor":"Pfizer","startDate":"2002-09","conditions":["Colectomy"],"enrollment":60,"completionDate":"2005-01"},{"nctId":"NCT00651300","phase":"PHASE3","title":"A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery","status":"TERMINATED","sponsor":"Pfizer","startDate":"2003-04","conditions":["Pain"],"enrollment":91,"completionDate":"2004-03"},{"nctId":"NCT00419549","phase":"PHASE2,PHASE3","title":"Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)","status":"TERMINATED","sponsor":"All India Institute of Medical Sciences","startDate":"2003-10","conditions":["ERCP","Pancreatitis"],"enrollment":371,"completionDate":"2005-09"},{"nctId":"NCT00636064","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-01","conditions":["Pain"],"enrollment":1671,"completionDate":"2004-01"},{"nctId":"NCT00763997","phase":"NA","title":"Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages","status":"COMPLETED","sponsor":"Ruhr University of Bochum","startDate":"2004-02","conditions":["Platelet Aggregation"],"enrollment":80,"completionDate":"2004-12"},{"nctId":"NCT00139646","phase":"PHASE3","title":"Parecoxib in Renal Colic","status":"TERMINATED","sponsor":"Pfizer","startDate":"2002-04","conditions":["Colic"],"enrollment":50,"completionDate":"2004-04"},{"nctId":"NCT00660855","phase":"PHASE4","title":"A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain","status":"TERMINATED","sponsor":"Pfizer","startDate":"2004-06","conditions":["Pain, Post Surgical"],"enrollment":4,"completionDate":"2004-07"},{"nctId":"NCT00143169","phase":"PHASE3","title":"Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain","status":"COMPLETED","sponsor":"Pfizer","startDate":"2004-09","conditions":["Pain, Postoperative"],"enrollment":220,"completionDate":"2005-06"}],"_emaApprovals":[{"date":"2002-03-22","status":"Authorised","company":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"009631","UNII":"9TUW81Y3CE","CHEBI":"CHEBI:73038","INN_ID":"7816","RXNORM":"279950","UMLSCUI":"C0915142","chemblId":"CHEMBL1206690","ChEMBL_ID":"CHEMBL1206690","KEGG_DRUG":"D03716","DRUGBANK_ID":"DB08439","PDB_CHEM_ID":" PXB","PUBCHEM_CID":"119828","SNOMEDCT_US":"395289008","IUPHAR_LIGAND_ID":"2895","SECONDARY_CAS_RN":"198470-85-8","MESH_SUPPLEMENTAL_RECORD_UI":"C409945"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":732,"therapeuticAreas":["Pain"],"atcClassification":{"source":"DrugCentral","atcCode":"M01AH04","allCodes":["M01AH04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"2002","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T01:57:00.293225+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}